| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $363K | +78.7% |
| SG&A Expense | $1.1M | -61.9% |
| Operating Income | -$1.8M | +42.9% |
| Pre-tax Income | $5K | +168.8% |
| Income Tax | $0 | — |
| Net Income | -$1.8M | +43.0% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | -42.8% |
| Current Assets | $2.1M | -42.8% |
| Total Assets | $2.1M | -42.6% |
| Current Liabilities | $8K | -18.7% |
| Stockholders' Equity | -$1.4M | -728.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.6M | -36.1% |